We can’t end AIDS without tackling patent abuse
News OpinionDespite significant scientific advancements for HIV, along with global and national commitments to ‘end AIDS’, hundreds of thousands of people...
Read more about We can’t end AIDS without tackling patent abuse
What’s wrong with IP rights? Protecting medicines from competition can be costly
NewsGram for gram a HIV medicine costs more than gold. What makes drugs so costly? Is it research and development?...
Read more about What’s wrong with IP rights? Protecting medicines from competition can be costly
Civil society key in TRIPS flexibility implementation
NewsCivil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...
Read more about Civil society key in TRIPS flexibility implementation